The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)

The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)

Cytomegalovirus (CMV) is a leading cause of congenital infections and significant health complications in immunocompromised individuals. With no licensed CMV vaccine available, the development of the mRNA-1647 offers promising advancements in CMV prevention. We have reviewed results from Phase 1 and...

Full description

Saved in:
Bibliographic Details
Main Authors: Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole, Kolade Adegoke, Akpevwe Emmanuella Benson, Paul Ayomide Jombo, Sandra Uchechukwu Eboson, Victor Oluwasola, Ademola Aiyenuro
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Cytomegalovirus
mRNA-1647
vaccine
congenital infection
immunogenicity
public health
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2450045
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items